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In lymphocyte transformation studies using optimal 
concentrations of P. orbiculare and C. albicans extracts, 
positive t·esponses were found in 31 of 32 normal human 
subjects to the former and 44 of 49 to the latter. The 
overall degree of sensitivity to extracts of the 2 orga-
nisms as judged by stimulation ratios was not signifi-
cantly different. The organisms did not appear to cross-
react in lymphocyte transformation tests, and in individ-
ual human subjects tested with both organisms, a strong 
response to one did not correlate with a strong response 
to the other. Extracts of neither organism contained 
substances suppressive of lymphocyte transformation. 
P. orbiculare extracts appeared to be significantly less 
antigenic than those of C. albicans, whether tested 
against naturally-sensitized humans or artificially-sen-
sitized guinea pigs even though the same amount of 
protein was extractable from each organism. Therefore, 
these studies indicate that P. orbiculare has been as 
successful as C. albicans in producing sensitization 
against its antigens in the general human population. 
However, P. orbiculare appears to be significantly less 
antigenic than is C. albicans, a finding which might be 
related to the relative lack of inflammation in lesions 
produced by P. orbiculare, and the rather high incidence 
of chronic tinea versicolor as compared to chronic mu-
cocutaneous candidiasis. 
Pityrosporum orbiculare (the presumed etiologic agent of 
t inea versicolor) and Candida albican.s are dimorphic fungi 
which can produce superficia l cutaneous infections in humans. 
Although in cutaneous infections, the invasion of both orga-
nisms is usua lly confined to the stratum corneum [1,2], the site 
of infection is actually in tracellular (3], and extends to t he 
deepest levels of this layer in tinea versicolor as weiJ as in 
c uta neous candidias is (3]. However, whereas P. orbicu.lare pro-
duces minimally inflammatory skin lesions that are frequently 
c hronic a nd recurrent (1], the cutaneo us infections produced by 
C. albicans are highly infla mmatory, and chronic superficia l 
infections caused by the latter orga nism (chroni c mucocuta-
n eous candidiasis) are quite rare (2]. At present, it is not clea r 
what mechanism is responsible for the inflammation in t he 
c utaneous lesions produced by these 2 organisms, a nd the 
relationship between inflammation and the actual defense 
against infection is a lso as yet unexpla ined. However, in de r-
matophytosis, a related infection , it appears from clini ca l ob-
servation that highly inflammatory infec tions are ra rely 
chronic, and that chronic ones are rarely highly in11ammatory 
[ 4]. 
Present evidence indicates that cell -mediated immuni ty plays 
a major role in the defense against chronic superficia l funga l 
infections. This conclusion is supported by the following obse r- . 
vations: (a ) D efective cell -mediated immunity against the in -
fecting organism has been fo und to be the major host defense 
defect in chroni c mucocutaneous candidiasis [2,5,6], chronic 
tinea versicolor [7], and chronic dermatophytosis [8,9]; (b) 
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children with inborn deficiencies of cell-mediated immunity are 
predisposed to chronic superficia l candidiasis [10]; and (c) res-
toration of cell-mediated immuni ty against C. albican.s through 
the use of transfe r factor or lymphocyte transfusions has re-
sulted in clinical benefit in some patients with ch1·onic muco-
cutaneous candidiasis (2,11]. Using the model of experimental 
dermatophytic infections in guinea pigs, it has been demon-
strated that cell-mediated immunity best explains the infla m-
mation which occurs in the infected skin [1 2]. However, com-
plement activation migh t play a rol e in producing inflammation 
in the cutaneous lesions of some patients wi th chronic muco-
cutaneous candidiasis [13], a nd this mechanism may be related 
to host defense in acute, experimental cutaneous C. albicans in 
animals [14]. 
One possible explanation for t he differ ences in the frequ ency 
of chronic infections and the amount of inflammation· produced 
by P. orbiculate and C. albicans migh t. be t hat the form er is 
less a ble to elicit reactions of cell-mediated immuni ty (i.e. , is 
less antigenic) than the latter . Therefore, even though an in-
fected person might be systemically sensit ized to these orga -
nisms, the infection migh t escape detection by the host defense 
system if the organisms contained a suffic ient ly smaiJ content 
of antigenic materia l. To test this hypoth esis, extracts were 
prepared by several methods from both organisms a nd qua nt i-
tatively tested for their ability to eli cit reactions of cell-me-
diated immunity in both naturally-sensitized human subj ects 
and artificially-sensit ized guinea pigs. 
MATERIALS AND METHODS 
Human Subject~ 
Normal human ubjects drawn from the medical students, house 
officers, and laboratory personnel of this institution were eva luated fo r 
responsiveness to these organisms by lymphocyte transformation as-
says using peripheral blood lymphocytes. The age range of these 
subjects was 20-42, and persons with a history of tinea versicolor, 
Candida infection, or dermatophytosis were excluded from the study. 
Of these subj ect , 49 were tested against extracts of C. albicans, 32 
aga inst extracts of P. orbiculare, and 31 against bot.h. 
Anim.crls 
Adu lt outbred guinea pigs of either the Har tley or English shorlhair 
strains were used in the animal studies. Animals of t.he same strain, 
age, and sex were used in each set of experiment s. 
Organisms 
Four strains of P. orbiculare were obtained from skin scrapings of 
tinea versicolor lesions by culture on mycosel agar (BBL, Div. Becton, 
Dickinson & Co., Cockeysvill e, Maryland) overlaid wit.h sterile olive oil. 
Subcul tures were made from emerging colonies and identified as P. 
orbiculare by morphologic appearance and a strict. requirement for 
added li pid. All 4 strains grew preferentially at. the oil -wa ter in terface 
of broth cul tures, although one strain wou ld also grow in the wat er 
phase and could be centrifuged free of oi l if O.l % Tween 80 were added 
to the medium. 
Of the 4 strains of C. albica.ns used in these studies, 2 were recent 
clinical isolates and 2 were post isolates mainta ined by repeated pas-
sage. Dr. V. P. Kurup (VA Medical Center, Wood, Wisconsin), kindly 
provided the culture of A. fumigatus. 
P. orbiculare and C. albicans were grown in bulk in Sabouraud 's 
dextrose broth containing chloramph enicol (20 f.Lg/ ml) and cyclohexi-
mide (40 {tg/ ml) , 0.1 % Tween 80, and overlaid wi th sterile olive oil. At 
the end of the cul ture period ( 14 clays for P. orbicu/(IJ:e and 5 days for 
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C. albicans), t he o il and wate r phases were sepa rated by centrifugation 
and each cent rifuged aga in to remove the organisms. The latte r were 
wa heel 3 Limes in 0.9% NaCI before the extrac ts were prepared. P. 
orbiculare was obtained primarily from the oil phase of the medium 
and C. albican.s from the water ph ase. A. fumigatus was grown in bulk 
in the above medium without olive oil for 14 days and then separated 
from the medium by filtration and washed 3 times in saline. 
Preparation of Extracts 
Extracts of P . orbiculare and C. albicans were prepared in pa rallel 
by 4 different methods: (a) ether extraction and mechanical grinding, 
as described previously [7]; brie fly, the organisms were extracted 3 
times in 3 volumes of ether, mixed with phosphate-buffered saline (pH 
7.4), and centrifuged; the pellet was ground for 20 min with glass beads, 
combined with the preceding supernatant, centrifuged, dialyzed aga inst 
saline, and sterili zed by fil tration; (b) ether extrac tion, as described 
above, bu t without mechanical grinding of the pell et; (c) freezing and 
thawing which was carried out us ing a dry ice-ethanol mixture and a 
37°C water bath to freeze and thaw a 20% suspension of organisms in 
saline 10 t imes; the suspension was then cent rifuged a nd the superna-
tant sterilized by fil tration; (d) sonication, using a Biosonics sonifier al 
maxima l in tensity for two 5-min periods to dis rupt organisms in a 40% 
suspension in saline; t he suspension was then centrifuged and the 
supernatant sterilized by fil tration. The extract of A. fwnigatu.s was 
prepared by grinding the washed mycelia in a mortar and pestle for 20 
min with glass beads, mixing with saline, then centrifuging and steriliz-
ing the supernatant by filtration. Prote in concentrations of a ll extracts 
were determined by the Lowry technique. 
As noted a bove, only 1 of the 4 stra ins of P. orbiculare could be 
obtained suspended in the water ph ase ra ther than the oil phase of the 
cul ture medium. Therefore, whereas extracts of a ll 4 strains could be 
prepared using e ither of the ether extraction methods, ex tracts by the 
sonication a nd freeze-thaw method which used organisms suspended in 
saline were obtained only from this one s train. In addition, satisfactory 
growth supernatant preparations could not be prepared from P. orbi· 
culare because the organisms produced an oil -in-wate r emu! ion which 
was unsuitable for this purpose. 
As reported previously [7] , s ince it is possible that media components 
might be inoorporated into some of these extracts, we have made 
contro l prepara tions from both the olive oil and Sabouraud's broth, and 
found that they do not elicit posit ive lymphocyte transformation re-
sponses in normal human subjects. 
lnununization of Animals 
For the tudies of antigen content, the anima ls (Hartley strain) were 
immunized by inj ec tion in to each footpad of 0.1 cc of a 1:1 emulsion of 
a 5% suspension conta ining equal volumes of both organisms (heal-
ki lled) in F reund 's complete adjuvant. For the analysis of possible 
inhibito ry properties of extracts from the two organisms, Hartley guinea 
pigs were immunized with a third organism, Aspergillus fwnigatu. s, by 
injection in to each footpad of 0.1 cc of a 1. : l emuls ion of an extract of 
A. fwnigatu.8 (prepared by mecha nical grinding and containing 300 /lg 
of prote in / ml) in complete Freund 's adj uvant. In the studies of cross-
reactivi ty between P. orbiculare and C. albicans, English shorthair 
guinea pigs were immunized with extracts of either organism (prepared 
by ether extraction and mechanical grinding as described below) by 
injection in to each footpad of 0.1 ml of a 1:1 emulsion of the extract 
(conta ining approximately 600 /lg of protein/ ml) in Freund 's complete 
adjuvant. All animals were tested approximately 2-3 mo after immu-
nization . 
S hin Tests 
Guin~a pigs immunized with both organisms were tested by in tra-
dermal injections of 0.1 ml of Yw, 1/ 10o, and 1/ """' dilutions of 3 extracts of 
each organi~m prepared by parallel methods. At 18 hr, the sites were 
examined in a blind fashion and the mm of induration recorded for each 
dilution with 5 mm being regarded as a positive test. 
Lymphocyte Transformation 
T he methods for this type of assay have been described previously 
[7l Briefly, in humans, mononuclear ce lls were isolated from peripheral 
blood by H ypaque-Fico ll cent rifugation and suspended at 0.25 X 10"/ 
ml in t rip licate 0.4 mJ a liquo ts in tissue cul ture medium RPMI 1640 
(G rand 1sla nd Biologic Co., Grand Is land, New York) with 15% a uto l-
ogous plasma and added penicillin, streptomycin , and glutamine. The 
cells were cul tured with 10-fo ld d ilutions of the va rious ex tracts for 5 
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days in 5% COt , at which poin t l.O 11Ci of tritiated thymidine (Schwa rz; 
Mann, Div. of Becton, Dickinson & Co., Orangeburg, New York) was 
added to each tube and the lymphocytes harvested onto glass fibe 1• 
strips 24 hr late r and counted by scintillat ion counting. Lympho<.;yte 
transform ation in guinea pigs was assayed by add ing 40 JLl of heparinized 
peripheral blood directly to 0.4 ml of RPM I 1640 medium suppl emented 
with penicillin, s treptomycin, and glu tamine. Tri tiated thymidine was 
added a fter 4 days of cul ture and the ce lls ha rvested onto glass fibe 1• 
strips and counted 24 hr late r a fter removal of the red blood ce lls us ing 
Zap-Isoton (Cou lter Electronics, ln<.; ., Hialeah, Plorida). The optima l 
incuba t ion period had been determined in both systems by prel imina ry 
experiments. In either sys tem, a positive re~ponse was defined as counts 
per minu te (CPM) > 3000 and stimulation ratio > 4.0. 
Determination of Antigenicity 
Antigenicity of the extracts was evaluated by de termining th e ir 
ab ili ty to s timulate lymphocyte transforma tion responses by lymph o-
cytes from normal human subjects a nd immu nized guinea pigs a nd 
delayed skin test responses in the immunized animals. T en-fold d ilu-
t ions of para lle.l extracts of the 2 organisms were added to cultures of 
human or guinea pig lymphocytes, incubated for the appropriate time, 
a nd har ves ted as described above. To obtain the endpoint, log,., of th e 
dilutions used were plotted aga ins t the resulting stimulation ra tios and 
the dilution producing a stimulation ratio of 4.0 dete rmined. S imilarly, 
the endpoints for the studies using skin tests were determined by 
plotting the dilutions used against the resulting mm of indmation 
produced, and the dilution producing 5 mm of induration determined . 
The data were expressed by two methods: (a) As the logw of the dilution 
of each extract (corrected to represent a constant volume of organisms 
extracted) required to convert a positive response to negative and (b) 
the ng/ ml of extract protein required for a positive response. The 2 
different methods of expression were necessary to control for possible 
inaccuracies in determining the starting volumes of the 2 organisms, 
and for the possibility that one organism might be extracted more 
efficiently than the other. 
Lymphocyte transformation tests were performed using lymphocytes 
from 5 human subjects and/or 5 gu inea pigs and skin tests in 4 gu inea 
pigs. In the lymphocyte transformation tests, the gu inea pigs were 
immunized with both organisms so that the same animals could be used 
to compare extracts of the 2 organisms, s ince we have observed some 
variability of lymphocyte transformation responses between differen t 
anima ls. All of the guinea pigs and human subjec ts demonstrated 
positive lymphocyte t ransformation responses to optimal concentra-
tions of extracts of both organisms. 
Evaluation of Cro.ss- reactiuity B etween C. a lbicans and P. orbicular e 
In order to determine whether or not the 2 organisms were immu-
nologica lly cross- reactive, groups of 6 guinea pigs were immunized with 
extracts of either C. albica.ns or P. orbiculare. The animals were then 
tes ted with extracts of both organ isms in lymphocyte transformation 
studies to determine if immunization with one produced cross-sensitiv-
ity to the other. 
Statistics 
All statistical evaluat ions based on data derived from 10-fold dilu-
tions of the extracts were carried out us ing log,., transformed data. 
Compa risons between means were performed using the unpaired t-test. 
Data expressed as number posit ive/total were compared using the Chi-
square test. Corre lations between variables were performed using the 
P earson correla tion coefficient [15], expressed as r. The level of signif-
icance in a ll tests was taken asp < .05. 
RESULTS 
Extracts 
Four strains of each organism were used in these studies a nd 
a total of 8 extrac ts prepa red from the P. orbiculare strains a nd 
8 from the C. albicans stra ins. Two extracts of each organism 
were prepared by each of t he four methods. As shown in Table 
I, the amount of protein obtainable by t hese procedures from 
a constant volume of organisms (wet volume determined by 
centrifugation at 2000 g in a graduated centrifuge tube) varied 
from extract to extrac.t, but was s imilar for the 2 organisms. 
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TABLE I. Extracts of P. orbicula re and C. a lbicans 
P. orbiculare C. albicans 
Extr.acl 
mg mg number/' Strai n protein/ ml Strain prote in/ ml 
organu.;m orgamsm 
EG, 1 2.10 1 4.23 
EG" 2 3.57 2 1.06 
E , 3 0.69 3 ].97 
E::! 4 2.27 4 1.05 
s, ,, 9.50 l 7.25 
s" 4 4. 13 1 9.38 
FT, 4 9.25 4 5.65 
FT" 4 4.75 1.40 
Mean± SE" 4.53 ± 1.15 4.00 ± 1.12 
" Extracts: EG=ether extraction and mecha nical grinding; E=ethe r 
extraction only; S=sonicate; FT=freeze-thaw. 
" M eahs a re not statistica lly significantly different by t he unpa ired/.-
test. 
Bachground Sensitivity toP. orbiculare and C. a lbicans in 
Normal Human Subjects 
Various concentrations of severa l extracts from both orga-
nisms were tested in preliminary studies to determine the one 
giving maximal lymphocyte t ransformation responses in re-
sponding subjects. Normal subjects were then tested with the 
optimal concentrations of the most active extract fron1 each 
organism. As shown in Table II, lymphocyte transformation 
tests were positive in 31/32 persons tested against P. orbiculare 
a nd 44/49 tested against C. albicans (p=NS). The mean stim-
ulation ratios were not statistically significantly different be-
tween the 2 groups. In addition, in the group of 31 subjects 
tested against both organisms, there was no significant corre-
lation between the stimulation ratios for the 2 organisms. 
Relative Antigenicity o( P. orbiculare and C. albicans in 
Humans 
Lymphocytes from normal human subjects were used to 
assay the extracts for relative antigenicity by determining the 
minimal concentrations of each extract which were capable of 
elicit ing positive lymphocyte transformation responses using 
10-fold dilutions of t he extracts as described in t he methods 
section. Table III shows the resul ts of this evaluation for all 4 
strains of both organisms using extracts prepared by ether 
extraction alone or ether extraction plus mechanical grinding. 
With endpoints expressed as fina l dilu tion of extracts pre par ed 
fro m a constan t volume of organisms, or as ng/ ml of e xtract 
protein, it is apparent that there is a statistically significant 
clifference between the 2 organisms in their quantitative ability 
to elicit this type of response. These data demonstrate tnat the 
C. albicans extracts a re approx imately 30 times as active as are 
those of P. orbiculare (30.9 times as expressed by dilu tion , 32.4 
times as expressed by ng/ml of extract protein required for a 
positive response). 
As shown in Table IV, the evaluation of extracts prepared by 
either sonication or freezing and thawing again showed a statis-
tically significant difference between the 2 organisms, using the 
data expressed as either final dilution or ng/ml of extract 
protein. When the ratios between the organisms are calct.Jlated, 
the C. albicans extracts are 66.6 as active as those of P. 
orbiculare based on fin al dilution, or 81.3 t imes as active based 
on ng/ ml of extract protein required for a positive response. 
Relative Antigenicity o(P . orbiculare and C. albicans in 
Immunized Guinea Pigs 
Because it is not known how normal humans become sensi-
tized to t hese 2 organisms and because differences in the 
strength of sensit ivity between individuals could affect the 
analysis of antigen icity, similar studies were carried out in 
guinea pigs artificial ly immunized aga inst both organisms. As 
shown in Table V, using t he lymphocyte tra_nsformation assay 
for antigenicity with endpoints expressed as either final dilution 
or ng of extract protein, the C. albicans extracts again appeared 
to be significantly more active tha n those of P. orbiculare. 
Calculati ng the ratios between the values for each organism 
TAIILI' II. Incidence and streng th of lymphocyte transfonnation 
reactions to P. orbiculare and C. a lbicans in normal human subj ects 
tl posit ive/ t1 tested 
Mean stimulation ratio 
±SE 
P. orbiculare 
31/ 32 
26.5 ± 4.2 
C. albicans 
44 / 49 
32.0 ± 4.8 
" Statistica l significance by Chi-squa re a na lysis. 
St.at.isticnl 
s igni ficance 
p = NS" 
p = NS'' 
1
' Statistica l significance by the unpa ired t-test.. Corre lation coeffi-
cien t of responses toP. orbicula.re a nd C. albicans in 31 subjects tested 
wit h both was 0.404 , p=NS. 
TADLE Ill. R elative antigenicity in humans o(P. orbicula re and C. 
albicans ether extract::; (4 strains of each) 
Endpoinl as final dilu l ion" 
P. orbiculare C. albicans 
Strain il Method" End point Strain il Method'' Endpoin t. 
l .EG 2.62 I EG 3.87 
2 .EG 1.31 2 EG 3.15 
3 E 2.02 3 E 3.81 
4 E 1.02 4 E 2.08 
M ean± SE'' 1.74 ± 0.36 3.23 ± 0.42 
Endpoint in ng/ ml" 
l EG 3.70 EG 2.76 
2 EG 5.25 2 EG 2.89 
3 E 3.82 3 E 2.50 
4 E 5.34 4 E 3.94 
Mean ± SE'' 4.53 ± 0.44 3.02 ± 0.32 
"Log"' of t he dilu tion required to convert lo negative the lymphocyte 
transformation response in 5 normal subjects (mean). 
" Method : EG=ether extraction a nd mecha nical grinding; E=ether 
extraction alone. 
·· Means ar e sta tistica lly s ignificantly different. (p < .05) by the 
unpa ired t-lest. 
" Log 10 of ng/ ml of extract req uired for a positive response (mean of 
5 subjects). 
,. Means are statistica lly s ignificanlly d ifferent (p < .02) by t he 
unpa ired t-test. 
TADLE IV . R elative antigenicity in humanl:i ofP. orbiculare and C. 
albi7ans son.icates and freeze-thaw extracts 
Endpoint ns final dilution" 
P. orbiculare C. albicans 
Strain il Method'' Endpoint SLruin t.:: Method 1' Endpoint 
4 FT 1.81 4 FT 3.40 
4 FT 1.45 1 FT 2.57 
4 s 1.29 I s 3.33 
4 s 1.67 s 4.22 
Mean± SE'' 1.56 ± 0.12 3.38 ± 0.34 
Endpoin t in ng/ ml" . 
4 FT 5. 16 4 FT 3.52 
4 FT 5.22 FT 3.58 
4 s 5.69 s 3.54 
4 s 4.96 s 2.75 
Mean± S.E'' 5.26 ± 0.16 3.35 ± 0.20 
" Log 11 , of t hl:! dilution required to convert to negative the lymphocyte 
transformation response in 5 normal subjects (mean). 
" Methods: FT=freezing and t hawing; S=sonication. 
·· M eans are stalisl.ically s ignificanlly (p < .01) d ifferent by t he 
unpaired /-test. 
" Log 111 of ng/ ml of extract required for a positive response (mean of 
5 subjects). 
,. Means ar e statistically significant ly d iffere nt (p < .01) by t he 
unpa ired t-l.est. 
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TABLE V. Relative antigenicity of P. orbicula re a.nd C. a lbicans extracts in im.rnu.n.ized g uinea pigs 
Ly mphocyte l ra nsfonnation (5 guinea p i g~) 
· P. orbtcuLare 
Stra in II 
1 
4 
4 
Mean ± SE" 
Method'' 
EG 
E 
s 
Delayed skin tes ts (4 guinea pigs) 
1 EG 
4 E 
4 s 
M ean ± SE" 
Endpoint" 
Di lu t ion ng/ml 
2.03 
2.19 
3.31 
2.51 ± 0.40 
1.07 
0.12 
1.33 
0.84 ± 0.37 
4.29 
4.66 
3.78 
4.24 ± 0.26 
4.25 
5.12 
4.65 
4.67 ± 0.25 
Stra in II 
l 
4 
1 
1 
4 
l 
Method" 
EG 
E 
s 
EG 
E 
s 
C. a/b icans 
Endpoint" 
D ilution ng/ ml 
4.4 1 
4.38 
4.40 
4.40 ± 0.01 
2.07 
2.05 
2.71 
2.28 ± 0.22 
2.22 
1.92 
2.57 
2.24 ± 0.19 
3.55 
3.25 
3.30 
3.37 ± 0.09 
"Endpoint expressed as logw di lu tion required to conver t positive response to negative, or ng required for positive response. 
1
' Methods: EG=ether extraction a nd mechanical grinding; E=ether extraction a lone; S=sonication . 
c Mea ns are statistically significant ly different between the 2 organisms for endpoints expressed as dilution (p < .05) or ng/ ml (p < .02). 
" Means ar e statistically significantly different between t he two organisms for endpoin ts expressed as dilu t ion (p < .05) or ng/positive test (p 
< .02). 
TABLE VI. Cross-reactivity o( P. orbiculare and C. a lbicans in. 
immunized guinea pigs (lymphocyte tmn.sform.a tion tests) 
Immunized aga inst C. a.lbica!IR 
it positive" /11 
Extract tes ted M ea n CPM ± SE Mean SR ± SE 
P. orbiculare 
C. albica.ns 
1/6 
6/6 
Immunized aga inst P. orbicu lare 
P. orbicula.re 
C. albica.ns 
6/6 
0/6 
1,368 ± 553 
7,485 ± 1,774 
6,167 ± 1,482 
680 ± 86 
3.5 ± 1.5 
20.2 ± 6.7 
18.6 
1.7 
" A positive lymphocyte t ransformation is defined as CPM > 3000, 
SR > 4.0. 
30 
25 
20 
15 
10 
5 
0 
).l g / ml 
§ INDICATED EXTRACT ALONE 
r!i INDICATED EXTRACT PLUS 
l.:j£J A. furnigurus EXTRACT 1 JJ. g / m l 
1 5 50 50 5 50 50 5 50 50 5 50 
A. f u m lgii/IIS C ; J/IJ IC<It lS C <llbu::w s P orb1 culmv 
EXTRACT EXTRA CT EXTRACT EXTRACT 
J M ECHAN ICAL 
GR IND IN G\ 
/E Hl ER ) (SON ICATI ON) /ETH ER I 
50 5 50 
p Or/) IC /d, /1!' 
EXTRACT 
/SONI CATION ! 
, Lymphocyte transformation . responses (mean sti mulation ratio ± 
standaJ·d error) in 4 A . fumigatus-immunized guinea pigs to vru·ious 
extracts. Solid bars represent addition of the other extracts to 1 (.Lg/ml 
of A. fumigatus extract, a n an tigenic, but non-suppressive concentra-
tion. S ignifican t (p < .001) suppression of the response to 1.0 (.Lg/ml of 
t his extract is seen only wi th 50 (.Lg of the same extract, but not with 
e ither concent ration of the P. orbicu.lare or C. albican.s extracts. 
shows t hat C. albicans extracts are 77.6 t imes as active as those 
of P. orbiculare when the data are expressed as final dilu tion, 
and 100.0 times when the data are expressed as ng/ ml of extract 
protein. 
Delayed skin tests to dilu t ions of the extracts were also used 
to estimate the relative antigenicity of the 2 organisms. Again , 
the C. albicans extracts appeared to be significantly more 
active tha n did those of P. orbiculare with endpoints calculated 
either as final clilution or as ng of extract protein per positive 
test. Ratios between each organism show that C. albicans 
extracts are 27.6 times as active as those of P. orbiculare using 
data expressed as final dilution, a nd 20.0 t imes using data 
expressed as ng of extract protein. 
Cross-reactivity ofP. orbiculare and C. albicans 
As shown in Table VI, only 1 of 6 C. albicans-immunized 
guinea pigs reacted to the P. orbiculare extract, and 0 of 6 P. 
orbiculare-immunized guinea pigs reacted to the C. albicans 
extract. The one C. albicans-immunized animal which did react 
to P. orbiculare produced a much stronger reaction to the C. 
albicans extract. 
Analysis of Lymphocyte Transformation- suppressing Activity 
in Extracts of P. orbiculare and C. albicans 
It is possible that extracts of these organisms could contain 
substances capable of suppressing lymphocyte transformation 
which might interfere wi th the use of this test to determine 
antigenicity. We have found that extracts of Asperg illus fumi -
gatu.s are capable of suppressing lymphocyte transformation 
responses to either A. fwnigatu.s extracts or purified protein 
derivative (unpublished observations). Guinea pigs immunized 
wit h A. fwnigatu.s were used to analyze extracts of P. orbiculare 
and C. albicans for lymphocyte transformation-suppressing 
activity by determining their effect on the response to a low (1 
f.lg / ml) concentration of A. fwnigatus extract in comparison to 
a high (50 f.lg/ ml) suppressive concentration of th is extract. As 
shown in the Figure, 50 f.lg/ ml of A. fumiga.tus extract signifi-
cantly (p < .001) suppressed the lymphocyte transformation 
response to a lower concentration of this extract, whereas 
extracts of P. orbicula.re and C. albicans did not appear to have 
significant effects. 
DISCUSSION 
These studies demonstrate several factors about cell-me-
diated immune responses to P. orbiculare and C. albicans: (a) 
It appears that most young adults have been sensitized at som e 
t ime to the 2 organisms and that the overall degree of sensitivity 
to both is equivalent; (b) for each subject, the degree of sensi-
tivity to one organism does not correlate with that to the other; 
(c) the organisms do not cross-react in lymphocyte transfor-
mation tests; and (d) it requires 20-100 times as much P. 
orbiculare as C. albicans extract to trigger positive cell-me-
diated immune responses, depending upon the type of extract 
and particular methods used. It is not clear how normal human 
subjects have become sensitized to these 2 organisms. One 
possibility is that most normal persons have had minor infec-
tions with each organism that were enough to produce sensiti-
zation, although not' enough to produce noticeable lesions. On 
Sept. 1980 RELATIVE ANTIGENICITY OF P. ORBICULARE AND C. ALBICANS 283 
t he other hand, both organisms are normal human flora 
(16,17], and it is possible that a sufficient qul:'.ntity of antigen 
from these organisms is absorbed through skin or mucosal 
surfaces to produce sensitization. Since the organisms do not 
appear to cross-react and there is little correlation between the 
strength of sensitivity to each, it is likely that sensitization to 
each organism has developed independently. Therefore, it 
would appear from these data that the reason why chronic tinea 
versicolor is more frequent than chronic mucocutaneous can-
didiasis is not because P. orbiculare is less capable of inducing 
cell-mediated immunity in huma ns than is C. albicans. 
The findin g that a relatively high quantity of P. orbicula re 
extract is req uired to elicit cell-med iated immune responses 
tends to support our hypothesis that t his organism might 
con ta in less a ntige n than C. albican.s. However, since the 
methods used in this type of ana lysis are relatively indirect, it 
i.s possible t hat a rt ifacts could occur which would interfere with 
om· quantitative assessment of ant igen content. As discussed 
above, it is possible that humans a re more strongly sensitized 
to C. albicanli so that positive responses would be produced 
against lower concentrations of extracts from this organism. 
Optimal concentrations of extracts fi·om both organisms pro-
duced equiva lent lymphocyte transformation responses in all of 
the subjects tested (as well as in the 10 used individua lly to test 
extracts). In addition, P. orbiculare extracts appea red to be 
weaker a nt igeni ca lly in the guinea pig studies where exposur e 
to both organisms was identical. Another possibility is that P. 
orbiculare contains some substance toxic to lymphocyte t ra ns-
formation which would make extracts of t his organism appear 
less active than C. albican.s in this test. The studies in Asper-
gillus- immunized guinea pigs indicate that under the condi t ions 
employed in t hese studies, neither P. orbiculare nor C. albicans 
have this property, alt hough A. fwnigatus does. Other workers 
have found that extracts of C. albican.s can inhibi t lymphocyte 
transformation , although it would appea r that higher concen-
trations than those used in the present study are r equired [6 ]. 
It is also poss ible that C. albican.s is easier to extract than is P . 
orbiculare, resulting in a higher antige n content in extracts of 
the for mer organism. However, eq uivalent a moun ts of protein, 
the m ost important type of ant igen involved in cell-mediated 
immunity (18], were obtained from both organ isms. In addi tio n , 
several diffe rent extraction methods were used to avoid favoring 
one organ ism. Finally, since the infecting organ isms in both 
c onditions are in a different morphologic phase than the cul-
tured ones (prima rily pseudomycelia in infections, yeast in 
culture), it is possible that more o r less a nt igen might be 
released in actual infections t han is obta ined by the extractio n 
procedures. However, we would expect that this factor would 
affect both orga nisms eq ua lly. In summa ry, it appears likely 
fro m these studi es that P. orbiculare is indeed less a nt igenic 
than is C. a.lbicans. 
As ment ioned previously, one theory about the infla mmation 
which occurs in superficial fungal infections is that it is a 
manifestation of cell -mediated immune reactions against th e 
infecting organism [12]. Our findings wou ld indirectly suppott 
this hypothesis because we might expect that a less antigenic 
organism such as P. orbicula.re would produce less of a ceO-
mediated immune response and the refore less infla mmation 
than does one like C. albica.n.s, which is more ant igenic. How-
ever , any theory to expla in infla mmation in superficial fungal 
infections must take into account the role of complement in 
this process. As discussed above, this mecha nism may be re-
. sponsible for neut rophil accumulation a nd the development o f 
satelli te pustules in acute cuta neous candidiasis [14] and per-
haps in the production of infla mmation in the lesions of cer tain 
patients with chronic mucocutaneous candidiasis [13]. Both 
mecha nisms migh t be involved under certa in condi t ions. W e 
have previously reported that in experimental cutaneous C. 
a.lbica.ns infections in guinea pigs, those infections produced 
without occlusive dressings in nonimmune a nimals develop only 
small, iso lated papules which consist microscopically of neutro-
phil-conta ining epidermal microabscesses, whereas immunized 
a nimals or those which have received lymphocytes from im-
mune animals have the small papules plus confluent erythema 
in the infected skin (19]. It is likely, t herefore, that the confluent 
erythema represents a cell-mediated immune reaction to C. 
albica.n.s antigens in the infected skin . The present studies, 
t herefore, support the concept that the Jack of inflammatio n in 
t inea versicolor lesions might be due to the relatively low 
a n t igenic content of P. orbiculare, perhaps acting in combina-
tion with decreased immunological responsiveness to this or-
ga nism as previously described in these patients [7]. However, 
a n al ternative explanation based upon complement activation 
is also possible. 
In summary, these studies indicate that whereas a majority 
of young adults are sensit ized to both P. orbicula.re and C. 
a.lbica.ns, extracts of P. orbiculare are much less active anti-
genically than are those of C. a.lbica.n.s. T his finding might 
expla in the relative lack of inflammation in the lesions produced 
by P. orbiculare and the comparatively high incidence of 
chronic tinea versicolor. 
REFERENCES 
1. Baxter DL: Superficial and deep mycotic infections, Dermatology. 
Edited by SL Moschella, DM Pillsbury, HJ Hurley, Jr. W.B. 
Saunders & Co., Philadelphia, 1975, pp 621-707 
2. Kirkpatrick CI-1, Hich HH, Bennett JB: Chronic mucocutaneous 
candidiasis: Model-building in cellular immunity. Ann lnt Med 
74:955-978, 1971 
3. Montes LF: Systemic abnormali ties and the intracellular site of 
infections of the stratum corneum. JAMA 2I3:I469-1472, I970 
4. Jones HE, Harrell EH: Superfic ial funga l infections of the skin, 
Infectious Diseases, 2nd ed. Edited by PD 1-loeprich. 1-!aJ·per and 
Row, Hagerstown, MD, 1977, pp 836-846, chap 103 . 
5. Takeya K, Nomoto K, Matsumoto T, Miyake T, Himeno K: 
Chronic mucocutaneous candidiasis accompanied by enhanced 
antibody production. Clin Exp Jmmunol 25:497-500, 1976 
6. Fischer A, Ballet JJ , Griscelli C: Specific inhibition of in vitro 
Candida- induced lymphocyte proliferation by polysaccharidic 
antigens present in the serum of patients wi th chronic mucocu; 
ta n eo us candidiasis. J. Clin Invest 62:1 005- 1013, 1978 
7. Sohnle PG, Collins-Lech C: Cell-mediated immunity to Pityrospo-
rum orbiculare in tinea versicolor. J Clin Invest 62:45-53, 1978 
8. Jones HE, Heinhardt JI-1, Hinaldi MG: Model dermatophytosis in 
naturally- infected subjects. Arch Dermatol 110:369-374, 1974 
9. Hanifin JM, Hay LF, Lobitz WC, Jr: Immunological reactivi ty in 
dermatophytosis. Br J Dermatol 90:1 -8, 1974 
10. Provost T: Infections associated with T-cell dysfunction, Infection 
and the Compromised Host. Edited by JC Allen. Williams & 
Wilkins, Co., Baltimore, 1976, pp 49-80 
11. Kirkpatrick CH, Smith TK: Chronic mucocutaneous candidias is: 
Immunologic and antibiotic therapy. Ann Int Med 80:310-320, 
1974 
12. Kerbs S, Greenberg J , Jesrani K: Temporal correlation of lympho-
cyte blastogenesis, skin test. responses, and erythema dw·ing 
dermatophyte infections. Clin Exp Immunol 27:526- 530, 1977 
13. Sohnle PG, Frank MM, Kirkpatrick CH: Deposition of complement 
component in the cutaneous lesions of chronic mucocutaneous 
candidiasis. Clin Immunol Immunopath 5:340-350, 1976 
14 . Hay TL, Wuepper KD: Experimental cutaneous candidiasis in 
rodents. II. Hole of the stratum corneum barrier and serum 
complement as a med iator of a protective inflammatory response. 
Arch Dermatol 114:539-543, 1978 
15. Downie NM, Heath HW, editors: Correlation-The Pearson T, 
Basic Statistical Methods, 2nd ed. Harper and How, New York, 
1965, pp 78-94 
16. Roberts SOB: Pityrosporum orbiculare: 1ncidence and distribution 
on clinically normal skin. Br J Derma to! 81:264-269, 1969 
17. Cohen H, Roth FJ , Delgado E, Ahearn DG, Kaiser MI-l: Funga l 
flora of the human small and large intestine. New Eng! J Mecl 
280:638-64 1, 1969 . 
18. Grappel SF, Bishop CT, Blank F: Immunology of dermatophytes 
and dermatophytosis. Bact Hev 38:222-250, 1974 
19. Sohnle PG, Frank MM, Kirkpatrick CH: Mechanisms involved in 
elimination of organisms from experimental cut aneous Candida 
a.lbicans infections in guinea pigs. J lmmunol 117:523-530, 1976 
